Senolytic Therapeutics Company
.png)
Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells.
Technology:
AgeTech
Industry:
Alternative Medicine, Biopharma, Biotechnology, Drug Development, Medical, Medical Device, Pharmaceutical, Robotics
Headquarters:
European Union (EU)
Founded Date:
2017-01-01
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
7
Total Funding:
583303
Estimated Revenue:
$1M to $10M
Last Funding Date:
2018
Last Funding Type:
Grant
Register and Claim Ownership